U.S. CDC reports 176,617 deaths from coronavirus

(Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday said the number of deaths due to the new coronavirus had risen by 394 to 176,617 and reported 5,715,567 cases, an increase of 33,076 cases from its previous count.

The CDC reported its tally of cases of the respiratory illness known as COVID-19, caused by a new coronavirus, as of 4 p.m. ET on Aug. 24 versus its previous report a day earlier.

The CDC figures do not necessarily reflect cases reported by individual states.

(Reporting by Dania Nadeem in Bengaluru; Editing by Maju Samuel)

Pandemic pace slows worldwide except for southeast Asia, eastern Mediterranean: WHO

By Stephanie Nebehay

GENEVA (Reuters) – The COVID-19 pandemic is still expanding, but the rise in cases and deaths has slowed globally, except for southeast Asia and the eastern Mediterranean regions, the World Health Organization (WHO) said.

In its latest epidemiological update, issued on Monday night, it said that the Americas remains the hardest-hit region, accounting for half of newly reported cases and 62% of the 39,240 deaths worldwide in the past week.

More than 23.65 million people have been reported to be infected by the coronavirus globally and 811,895​ have died, according to a Reuters tally on Tuesday.

“Over 1.7 million new COVID-19 cases and 39,000 new deaths were reported to WHO for the week ending 23 August, a 4% decrease in the number of cases and (a 12% decrease) in the number of deaths compared to the previous week,” the WHO said.

Southeast Asia, the second most affected region, reported a jump accounting for 28% of new cases and 15% of deaths, it said. India continues to report the majority of cases, but the virus is also spreading rapidly in Nepal.

In WHO’s eastern Mediterranean region, the number of reported cases rose by 4%, but the number of reported deaths has consistently dropped over the last six weeks, the WHO said. Lebanon, Tunisia and Jordan reported the highest increase in cases compared to the previous week.

The number of cases and deaths reported across Africa decreased by 8% and 11% respectively in the past week, “primarily due to a decrease in cases reported in Algeria, Kenya, Ghana, Senegal and South Africa”, it said.

“In the European region, the number of cases reported has consistently increased over the last three weeks,” it said. “However, only a slight decrease (1%) was reported in the most recent week, and the number of deaths have continued to decrease across the region.”

In WHO’s western Pacific region, the number of new cases dropped by 5%, driven by less spread in Japan, Australia, Singapore, China and Vietnam. South Korea reported an 180% jump in cases, “mainly due to an increase in cases associated with religious gatherings”.

(Reporting by Stephanie Nebehay; Editing by Giles Elgood)

In California heatwave, pandemic makes it hard to cool off

By Sharon Bernstein

RANCHO CORDOVA, Calif. (Reuters) – Before the COVID-19 pandemic shut down air-conditioned shopping malls and movie theaters, Debera Diaz and her adult son Joshua could have ducked inside to escape the 109 degree Fahrenheit heat that roasted their town near Sacramento last week.

So the pair, who have been living in Debera’s Honda Civic since her divorce and eviction a few months ago, were grateful to find a cooling center in city hall, complete with masks and a showing of the Meryl Streep movie “The Devil Wears Prada.”

“You can’t even go to the library,” said Diaz, 58. “It was really bad.”

The coronavirus pandemic presents vexing challenges for officials trying to protect residents from extreme weather conditions. Many places people usually go are closed, and public cooling centers like the one in Rancho Cordova can only accept half the normal number of people because of physical distancing requirements. Staying with relatives or friends is also difficult because of health concerns.

At the same time, however, officials worry that fears of catching the virus will keep some vulnerable people from seeking shelter from extreme heat, or even seeking out evacuation centers when wildfire threatens.

Protecting residents from extreme conditions is an issue that increasingly confronts cities and counties across the United States, as storms, heat and wildfire force thousands to seek refuge. Many experts are even more concerned about how to shelter vulnerable residents from extreme cold should the pandemic still be raging in the winter.

“It’s changed how we approach this as a city,” Rancho Cordova Mayor David Sander said of the pandemic. In previous years, churches and nonprofits opened their doors to people seeking shelter, but now many are either closed or unable to help, he said.

The city’s cooling center, set up in a large meeting room, can only accommodate 10 people before workers have to open an adjoining room, Sander said. That is half or less than its usual capacity.

The city is not taking the temperatures of everyone who comes in but asks anyone with a self-reported fever to stay away.

Among those most likely to suffer from extreme weather are people without homes like the Diazes, and the elderly on fixed incomes who might not have air conditioning or, if they do, may feel that they can’t afford to use it, said Mary Jo Flynn-Nevins, the emergency operations coordinator for Sacramento County.

Public agencies opened eight cooling centers in the county during last week’s heatwave, each able to accommodate between 10 and 40 people, she said.

With more than 5,500 people homeless in Sacramento County last year, and around 225,000 elderly, space for residents to shelter from harsh weather can quickly run short, Flynn-Nevins said.

Statewide, cooling centers were opened in 24 of California’s 58 counties, according to the California Department of Emergency Services.

The administration of Democratic Governor Gavin Newsom did not respond to requests for comment about the challenges of offering respite from the heat during the pandemic. But the state has encouraged residents to limit their use of electricity to avoid overtaxing the power grid and prompting blackouts.

When the temperature neared 100 Fahrenheit in the Sherman Oaks section of Los Angeles, Magdalay Arriola went to the East Valley Adult Center, where she sat with a water bottle and portable lunch cooler, reading a book.

About 10 people, 6 feet apart and wearing masks, sat in the air-conditioned room. Employees in protective suits cleaned tables and chairs with disinfectant.

“The AC is not working in my house, and I was getting really overheated,” said Arriola, 55. “Hopefully this is safe.”

Her worry that the cooling center may not be safe from COVID-19 is common, said Chad Carter, a spokesman for the Red Cross. People also worry they may spread or contract the virus if they seek shelter with friends or family.

But they also must recognize the dangers of soaring temperatures, which include heat exhaustion and heat stroke.

“Extreme heat is a risk just like COVID-19,” he said. “Extreme heat can be deadly.”

(Additional reporting by Lucy Nicholson; Editing by Cynthia Osterman)

New U.S. COVID-19 cases drop for fifth week in a row, deaths decline

(Reuters) – The number of new cases of the novel coronavirus reported in the United States fell 17% last week, the fifth straight week of declines, according to a Reuters tally of state and county reports.

Nearly 1,000 people a day continue to die from COVID-19, though last week’s total of more than 6,700 deaths was down 9% from the previous seven days.

The United States posted 297,000 new cases for the week ended Aug. 23, down from a weekly peak of over 468,000 cases in mid-July. The country is now averaging less than 50,000 new infections a day for the first time since early June.

The United States still has the worst outbreak in the world, accounting for a quarter of the global total of 23 million cases.

The state with the biggest percentage increase in new cases last week was South Dakota at 50%. Infections have been rising since the annual motorcycle rally in Sturgis, which drew more than 100,000 people from all over the country from Aug. 7 to 16. The South Dakota health department was not immediately available for comment.

Cases rose by 30% in nearby North Dakota and by 24% in Wyoming.

The United States tested on average 675,000 people a day last week, down from a peak in late July of over 800,000 people a day.

Nationally, the share of all tests that came back positive for the new virus was 6.3%, down from 7% the prior week and below a peak of 9% in mid-July, according to data from The COVID Tracking Project, a volunteer-run effort to track the outbreak.

South Carolina had the highest positivity rate in the nation at 22%, followed by Texas, Nevada and Idaho at 16%.

At least 29 states reported a positivity rate above 5%, the level the World Health Organization considers concerning because it suggests there are more cases in the community that have not yet been uncovered.

(Writing by Lisa Shumaker; Graphic by Chris Canipe; Editing by Tiffany Wu)

Novavax starts enrollment for phase two of COVID-19 vaccine trial

(Reuters) – Novavax Inc said on Monday it has begun enrolling volunteers for the second phase of an ongoing clinical trial of its COVID-19 vaccine candidate, with interim data expected in the fourth quarter of 2020.

In the new phase, the age range has been expanded, with adults between 60 and 84 years accounting for nearly 50% of the trial’s population.

Early-stage data from a small clinical trial of the vaccine has shown it produced high levels of virus-fighting antibodies, and the company aims to begin larger studies to obtain regulatory approvals as early as December.

The vaccine candidate is one of nearly 30 being tested in human clinical trials globally and lags candidates from AstraZeneca, Pfizer and Moderna that are in late-stage studies.

The U.S. government in July awarded Novavax $1.6 billion to test and manufacture its vaccine in the United States, with the aim of delivering a 100 million doses by January.

Britain has also tied-up with the company to buy 60 million doses of its vaccine candidate, some of which will be made using Fujifilm Diosynth Biotechnologies facilities in Stockton-on-Tees, northern England.

The study is targeting enrollment of up to 1,500 healthy volunteers at up to 40 sites in the United States and Australia, Novavax said.

Last week, the drug developer began a mid-stage study of its COVID-19 vaccine in South Africa.

(Reporting by Ankur Banerjee and Vishwadha Chander in Bengaluru; Editing by Arun Koyyur)

Gilead remdesivir study finds only marginal benefit for moderate COVID-19 patients

By Deena Beasley

(Reuters) – Moderately ill COVID-19 patients saw their condition improve after a 5-day course of Gilead Sciences Inc’s remdesivir, but the drug did not significantly shorten hospital stays and a 10-day course did not show a benefit, according to new data.

The drug, which was shown in a trial of severely ill COVID-19 patients to shorten their hospital recovery time, has been at the forefront of the battle against the pandemic.

The 600-patient analysis, published on Friday by the Journal of the American Medical Association, found that moderately ill patients treated with the antiviral drug for up to 5 days had significantly higher odds of improvement in certain areas, such as whether or not they needed supplemental oxygen, compared to patients given standard treatment.

Researchers said the clinical importance of the benefit for those patients was uncertain, however.

Remdesivir is currently sold under an emergency use authorization from the U.S. Food and Drug Administration for treating patients hospitalized with severe COVID-19, the disease caused by the new coronavirus. Gilead earlier this month filed an application seeking full FDA approval of the drug.

Differing trial results for remdesivir raise “the question of whether the discrepancies are artifacts of study design choices, including patient populations, or whether the drug is less efficacious than hoped,” according to a JAMA editorial accompanying the study.

The new study in moderately ill COVID-19 patients showed that 11 days after starting treatment, 65% of the 10-day remdesivir patients, 70% of the 5-day patients and 60% of the standard care patients had left the hospital.

Side effects seen more frequently in the remdesivir groups included nausea, low blood potassium levels, and headache.

The JAMA editorial said important questions remain regarding the efficacy of remdesivir, including which patients are most likely to benefit from the drug, the optimal duration of therapy, the drug’s impact on clinical outcomes, and its relative effect if combined with generic steroid treatments.

(Reporting by Deena Beasley; Editing by Nick Tattersall and Sonya Hepinstall)

U.S. CDC reports 173,490 deaths from coronavirus

(Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) on Friday said the number of deaths due to the new coronavirus had risen by 1,074 to 173,490 and reported 5,551,793 cases, an increase of 44,864 cases from its previous count.

The CDC reported its tally of cases of the respiratory illness known as COVID-19, caused by a new coronavirus, as of 4 pm ET on Aug. 20 versus its previous report a day earlier.

The CDC figures do not necessarily reflect cases reported by individual states.

(Reporting by Dania Nadeem in Bengaluru; Editing by Devika Syamnath)

WHO chief hopes coronavirus pandemic will last less than two years

By Stephanie Nebehay

GENEVA (Reuters) – The World Health Organization hopes the coronavirus pandemic will be shorter than the 1918 Spanish flu and last less than two years, WHO chief Tedros Adhanom Ghebreyesus said on Friday, if the world unites and succeeds in finding a vaccine.

The WHO has always been cautious about giving estimates on how quickly the pandemic can be dealt with while there is no proven vaccine.

Tedros said the 1918 Spanish flu “took two years to stop”.

“And in our situation now with more technology, and of course with more connectiveness, the virus has a better chance of spreading, it can move fast because we are more connected now,” he told a briefing in Geneva.

“But at the same time we have also the technology to stop it and the knowledge to stop it. So we have a disadvantage of globalization, closeness, connectedness but an advantage of better technology.

“So we hope to finish this pandemic (in) less than two years.”

He urged “national unity” and “global solidarity”.

“That is really key with utilizing the available tools to the maximum and hoping that we can have additional tools like vaccine.”

More than 22.81 million people have been reported to be infected by the coronavirus globally since it was first identified in China last year and 793,382​ have died, according to a Reuters tally.

(Reporting by Stephanie Nebehay, Michael Shields and Jo Mason; Writing by Nick Macfie; Editing by Hugh Lawson)

New York City ahead of curve on COVID-19, but faces risks going into fall: experts

By Carl O’Donnell

NEW YORK (Reuters) – New York City, once an epicenter of the novel coronavirus outbreak, has managed to contain the virus as it reopens, but faces risks of an uptick in cases in the fall, public health experts told Reuters.

The city’s success comes from a mix of high rates of compliance with local and federal public health guidance and also substantial immunity among the general population, a result of the severity of the outbreak in March and April, according to public health experts based in New York City.

“There was an alignment in New York with the state government, the healthcare system and the media on what to do – namely, lock everything down,” said Mark Jarrett, chief quality officer at Northwell Health. “The lockdown didn’t please everyone but was really well accepted.”

That contrasts with other parts of the country, where political opposition to mask wearing and lockdowns is more widespread, Jarrett added.

The rate of contagion also declined more quickly because the initial outbreak left between 25% and 50% of New Yorkers with some level of immunity, said Maria Lima, associate dean for research at the City University of New York School of Medicine.

New York is at risk for an uptick in cases as schools reopen and cold weather pushes more people indoors, the experts said.

“The big challenge is schools reopening, recreating that density anew,” which had been reduced by social distancing, said Troy Tassier, a professor of economics at Fordham University who specializes in epidemiology.

After peaking in early April at a seven day average of more than 5,000 cases per day, New York City has reduced its daily case count to an average of less than 200, according to city data.

The percentage of people tested who turned out to have the virus declined from around 70% in late March to less than 1%, and confirmed deaths have declined from over 500 per day in April to the low single digits.

The United States as a whole continues to struggle to contain the virus, clocking upwards of 45,000 cases per day. Total cases have surpassed 5.5 million and more than 170,000 people have died.

(Reporting by Carl O’Donnell in New York; Editing by Daniel Wallis)

U.S. unfreezing Venezualan assets to help opposition fight COVID-19: Guaido

CARACAS (Reuters) – Venezuela’s opposition said on Thursday the United States has granted it access to millions of dollars of frozen Venezuelan government funds to support efforts to combat the spread of COVID-19 in the country.

The U.S. Treasury Department had approved the release of the funds, the opposition said in a statement without specifying the total amount.

The statement said part of the released funds would go to pay some 62,000 health workers $300. During a live appearance on Twitter on Thursday night, opposition leader Juan Guaido said health workers could register accounts to receive payments of $100 a month starting Monday.

Healthcare workers in Venezuela can earn as little as $5 a month.

Guaido first announced the additional support for healthcare workers four months ago, but distribution required a permit from the Office of Foreign Assets Control (OFAC), as the frozen funds were held by the New York Federal Reserve.

The opposition plans to distribute the funds using AirTM, a digital payment platform, but on Thursday, the website was blocked in Venezuela.

“You have to be very bad to block an account for men and women who are giving everything with conviction to protect our people when they are going to receive a bonus,” said Guaido.

The opposition leader added healthcare workers would be sent a manual with the steps to download a virtual private network (VPN) so they could circumvent the restrictions. AirTM also tweeted instructions how to use a VPN.

Guaido has been recognized by more than 50 countries as Venezuela’s rightful president after assuming an interim presidency in 2019 on the grounds that Maduro’s 2018 re-election was fraudulent.

In July, the opposition obtained permission to distribute $17 million in funds frozen in the United States that would be channeled through international health organizations to purchase supplies for medical workers.

The license also approves another $4.5 million to support Venezuelans at risk of death, an opposition press release said.

Venezuela is suffering economic collapse and its crumbling health system has so far registered 37,567 cases of COVID-19 and 311 deaths, although experts say the number is likely to be higher due to widespread insufficient testing.

(Reporting by Sarah Kinosian; Editing by Simon Cameron-Moore)